Clinical Trial Update: Efficacy and Safety of 500mg of Fulvestrant [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the efficacy and safety of a 500 mg dose of fulvestrant in breast cancer; the study is currently listed as active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Faslodex (fulvestrant)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING